Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients

NCT07473167 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed Large B-cell Lymphoma
Refractory Large B-cell Lymphoma
Diffuse Large B-cell Lymphoma (DLBCL)
High-grade B-cell Lymphoma (HGBL)
Transformed Follicular Lymphoma (TFL)
Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Interventions

DRUG: TC011

Sponsor

TICAROS Co., Ltd.